Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Human Alpha1-Proteinase Inhibitor (respiratory use)

EU orphan designation number: EU/3/01/044   
Active ingredient: Human Alpha1-Proteinase Inhibitor (respiratory use)
Indication: Treatment of emphysema secondary to congenital alpha 1-antitrypsin deficiency
Sponsor: CSL Behring GmbH
Emil-von-Behring-Straße 76, D-35041 Marburg, Deutschland

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
10/07/2001 Centralised Orphan - Designation EMEA/OD/045/00 (2001)1397 of 09/07/2001
07/02/2005 Other procedure
13/04/2007 Other procedure